Royal Philips released its Q4 17 results which were slightly below the street’s expectations. Comparable sales growth came in at +4.6% (vs AV’s estimate: +5.1%), wherein growth territories gained 7% (c.33% of Q4 17 sales; led by Central/Eastern Europe, Middle East and China) and mature geographies grew 3% (c.67% of Q4 17 sales; North America: +c.5%, Western Europe: +c.4%). Segment-wise details as follows: Momentum in the Personal Health/PH segment accelerated to +6.3% on a qoq bas
01 Feb 2018
Q4 a slight miss; but fundamentals remain intact
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q4 a slight miss; but fundamentals remain intact
Koninklijke Philips N.V. (PHIA:WBO) | 0 0 1.5% | Mkt Cap: 29,653m
- Published:
01 Feb 2018 -
Author:
Sumit Sayal -
Pages:
4
Royal Philips released its Q4 17 results which were slightly below the street’s expectations. Comparable sales growth came in at +4.6% (vs AV’s estimate: +5.1%), wherein growth territories gained 7% (c.33% of Q4 17 sales; led by Central/Eastern Europe, Middle East and China) and mature geographies grew 3% (c.67% of Q4 17 sales; North America: +c.5%, Western Europe: +c.4%). Segment-wise details as follows: Momentum in the Personal Health/PH segment accelerated to +6.3% on a qoq bas